Mild Cognitive Impairment (MCI) clinical trials
Showing 201–228 of 228 active trials. Describe your situation to see which ones look like a fit.
- Comparative Study of High Performance Low-Cost Optical Coherence Tomography (Stage 1B, 2 and 3)
- TMS Pilot in Early AD II
- Impact of Yoga on Cognitive Function
- Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry
- MR Elastography of Cognitive Impairment
- Integrating eSAGE With EHR Data Using Machine Learning for the Early Detection and Monitoring of Cognitive Impairment in Individuals
- Alzheimer's Disease Neuroimaging Initiative 4
- Alzheimer's Registry
- Neurophysiological Benefits of Live Music for Early Alzheimer's Patients and Their Caregivers
- Software Validation Study-Cognitive Status Indicator
- Tau PET Outcomes With Anti-amyloid Immunotherapies
- MIBG in Aging and Neurologic Disorders
- Quality Improvement and Practice Based Research in Neurology Using the EMR
- DaTSCAN Imaging in Aging and Neurodegenerative Disease
- Imaging of Brain Amyloid Plaques in the Aging Population
- Wisconsin Brain Donor Program
- Mid-frontal Delta/Theta and Cognitive Control
- Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
- The Digital Memory Notebook
- Impact of Intensive Computerized Cognitive Training
- A Clinical Trial of AAV2-BDNF Gene Therapy in Early Alzheimer's Disease and Mild Cognitive Impairment
- Rapamycin - Effects on Alzheimer's and Cognitive Health
- A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
- Brain Health Virtual Reality Study
- Discovery and Validation of Genetic Variants Affecting Microglial Activation in Alzheimer's Disease
- Effect of LEQEMBI on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer's Disease
- Longitudinal Early-onset Alzheimer's Disease Study Protocol
- LEADing Dementia End-of-Life Planning Conversations
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.